Summary: Standards
- Eligibility checking works remarkably well
- But users universally unaware
- No human assessment of dual-eligibles or possible false+ MPI matches
- Disappointing impact on formulary/cost but difficult to interpret
- NEWRX workhorse—extremely important
- Primary driver of surrogate adoption
- Persistent transmission reliability issues
- Most problems due to human factors @ pharmacy?
- Med Hx: Transaction is easy; workflow integration isn't
- NoFill clinically risky w/o true transaction; need order ID
- Prior Auth: not fully tested; big hit for providers
Previous Slide Contents Next Slide